We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Guidance on how to make reasonable adjustments to help support people with learning disabilities in using pharmacy services.
For manufacturers reporting adverse incidents with joint replacement implants under the vigilance system.
Outcomes from the first meeting with the regulators of medicine who had met globally to discuss dementia.
Report on how community pharmacies can improve the prevention, early detection and management of blood pressure.
On this page the Medicines and Healthcare Products Regulatory agency provides advice for producers of E-cigarette/vape products
Information on medical facilities available in Timor-Leste.
Outlines the level of payment due from members of the Pharmaceutical Price Regulation Scheme (PPRS) in 2018.
The Defence and Security Accelerator (DASA) is running a Market Exploration to explore research and technology development of relevance to the modelling of traumatic wounds and the monitoring of their progression.
Which product type to select when submitting a notification of intent to market e-cigarette and vape products in Northern Ireland.
Sets out the payment due from members of the voluntary scheme for branded medicines pricing and access in 2022.
Information on the measures in the Health Service Medical Supplies (Costs) Bill.
Information for healthcare professionals, patients, and the public.
Guidance on applying for a Marketing Authorisation for Decentralised Manufacture, including eligibility, process, and requirements.
Scientific advice queries on nanomedicines have increased in recent years, particularly on lipid nanoparticles.
Patient communication about a very low risk to patient safety in response to the field safety notice (FSN) issued by Diffuplast and MHRA.
An overview of the five technologies selected for the AI Airlock pilot.
How to report adverse incidents involving insulin infusion pumps and integrated meter systems under the vigilance system.
UK businesses can apply for a share of up to £8 million from the Industrial Strategy Challenge Fund for capital projects to improve medicines manufacturing.
This guidance is designed to provide information on the implementation of changes to advertising and promotion of medicines authorised in the UK from 1 January 2025.
Information for pharmaceutical wholesalers explaining the main changes the Windsor Framework introduces to the packaging for all medicines licensed in the UK, effective from 1 January 2025.
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).